Sodium Phosphate, Tribasic
CAS 7601-54-9
Sodium Phosphate, Tribasic (CAS 7601-54-9) is a pharmaceutical compound with 1 bioactivity target and 3 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Ki | 84 nM | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| SODIUM PHOSPHATE, TRIBASIC | 36710 | SU | MTHSPL |
| sodium phosphate, tribasic | 36710 | SU | MTHSPL |
| SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS | 1307158 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Sodium Phosphate, Tribasic used for in pharmaceutical contexts?
Sodium Phosphate, Tribasic (CAS 7601-54-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Sodium Phosphate, Tribasic?
Sodium Phosphate, Tribasic has 3 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Alopecia, Injection site bruising, Product quality issue. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Sodium Phosphate, Tribasic also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Trisodium Phosphate with EU status "permitted".
What clinical phase is Sodium Phosphate, Tribasic in?
No phase 1-4 clinical development badge is rendered for Sodium Phosphate, Tribasic because the matched compound identifier rows do not contain a max-phase value.